Key result
Non-robotic totally thoracoscopic ASD closure achieves 100% success without early deaths or residual shunts.
Why the study?
Minimally invasive surgical techniques for atrial septal defect are increasingly important, and the feasibility and safety of totally thoracoscopic operation without robotic systems needed evaluation.
Is totally thoracoscopic surgery feasible and safe for the treatment of atrial septal defect?
Observational (n=61)
No
Is totally thoracoscopic surgery feasible and safe for the treatment of atrial septal defect?
Totally thoracoscopic surgery without a robotic system is a feasible and safe minimally invasive option for the closure of atrial septal defects.
Answers are grounded in this paper and cite their sources.
May support non-robotic thoracoscopic ASD closure in experienced centers; leaves open randomized comparisons to sternotomy.
BACKGROUND: More and more surgeons and patients focus on the minimally invasive surgical techniques in the 21st century. Totally thoracoscopic operation provides another minimal invasive surgical option for patients with ASD (atrial septal defect). In this study, we reported our experience of 61 patients with atrial septal defect who underwent totally thoracoscopic operation and discussed the feasibility and safety of the new technique. METHODS: From January 2010 to October 2012, 61 patients with atrial septal defect underwent totally thoracoscopic closure but not traditional median sternotomy surgery. We divided the 61 patients into two groups based on the operation sequence. The data of group A (the first 30 cases) and group B (the last 31 cases). The mean age of the patients was 35.1 ± 12.8 years (range, 6.3 to 63.5 years), and mean weight was 52.7 ± 11.9 kg (range, 30.5 to 80 kg). Mean size of the atrial septal defect was 16.8 ± 11.3 mm (range, 13 to 39 mm) based on the description of the echocardiography. RESULTS: All patients underwent totally thoracoscopy successfully, 36 patients with pericardium patch and 25 patients were sutured directly. 7 patients underwent concomitant tricuspid valvuloplasty with Key technique. No death, reoperation or complete atrioventricular block occurred. The mean time of cardiopulmonary bypass was 68.5 ± 19.1 min (range, 31.0 to 153.0 min), the mean time of aortic cross-clamp was 27.2 ± 11.3 min (range, 0.0 to 80.0 min) and the mean time of operation was 149.8 ± 35.7 min (range, 63.0 to 300.0 min). Postoperative mechanical ventilation averaged 4.9 ± 2.5 hours (range, 3.5 to 12.6 hours), and the duration of intensive care unit stay 20.0 ± 4.8 hours (range, 15.5 to 25 hours). The mean volume of blood drainage was 158 ± 38 ml (range, 51 to 800 ml). No death, residual shunt, lung atelectasis or moderate tricuspid regurgitation was found at 3-month follow-up. CONCLUSION: The totally thoracoscopic operation is feasible and safe for patients with ASD, even with or without tricuspid regurgitation. This technique provides another minimal invasive surgical option for patients with atrial septal defect.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2013) conducted an observational in Atrial septal defect (n=61). Totally thoracoscopic surgery without robotic assistance was evaluated on Successful totally thoracoscopic closure.
Synapse has enriched 10 related papers. Consider them for comparative context: